Skip to main content

Medicines and Healthcare Products Regulatory Agency

Question for Department of Health

UIN 62400, tabled on 31 January 2017

To ask the Secretary of State for Health, what steps his Department is taking to increase the capacity of the Medicines and Healthcare Products Regulatory Agency as a result of the UK leaving the EU.

Answered on

8 February 2017

The Government is assessing fully how the United Kingdom’s decision to leave the European Union will impact on medicines regulation in the UK, including the future role of the Medicines and Healthcare products Regulatory Agency and its capacity requirements.